Countries citing papers authored by Nikolas Tsavaris
Since
Specialization
Citations
This map shows the geographic impact of Nikolas Tsavaris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikolas Tsavaris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikolas Tsavaris more than expected).
Fields of papers citing papers by Nikolas Tsavaris
This network shows the impact of papers produced by Nikolas Tsavaris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikolas Tsavaris. The network helps show where Nikolas Tsavaris may publish in the future.
Co-authorship network of co-authors of Nikolas Tsavaris
This figure shows the co-authorship network connecting the top 25 collaborators of Nikolas Tsavaris.
A scholar is included among the top collaborators of Nikolas Tsavaris based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Nikolas Tsavaris. Nikolas Tsavaris is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
11 of 11 papers shown
1.
Syrios, John, George Agrogiannis, Ioannis Xynos, et al.. (2013). DNA ploidy: a prognostic factor of response to chemotherapy and survival in metastatic gastric adenocarcinoma.. PubMed. 33(3). 1209–14.3 indexed citations
2.
Karatzas, Theodore, John Grınıatsos, Dimitrios Dimitroulis, et al.. (2012). Modified docetaxel-cisplatin in combination with capecitabine as first-line treatment in metastatic gastric cancer. a phase II study.. PubMed. 32(9). 4151–6.9 indexed citations
3.
Xynos, Ioannis, Andreas C. Lazaris, Christos Kosmas, et al.. (2010). Predictors of survival in stage IV metastatic colorectal cancer.. PubMed. 30(2). 653–60.88 indexed citations
4.
Tsavaris, Nikolas, Helen Gogas, Evangelos Felekouras, et al.. (2009). Cisplatin-Ifosfamide-gemcitabine as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and Paclitaxel.. PubMed. 29(7). 2681–6.2 indexed citations
5.
Gogas, Helen, et al.. (2009). Salvage chemotherapy with oxaliplatin and capecitabine for breast cancer patients pretreated with anthracyclines and taxanes.. PubMed. 29(7). 2851–6.10 indexed citations
Kosmas, Christos, Nikolas Tsavaris, Helen Gogas, et al.. (2007). Paclitaxel-ifosfamide-cisplatin as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and paclitaxel.. PubMed. 27(3B). 1645–51.5 indexed citations
8.
Tsavaris, Nikolas, Christos Kosmas, Αθανάσιος Γιαννόπουλος, et al.. (2006). Subsets of patients with advanced gastric cancer responding to second-line chemotherapy with docetaxel-cisplatin.. PubMed. 26(5B). 3749–53.10 indexed citations
Tsavaris, Nikolas, Christos Kosmas, Maria Vadiaka, et al.. (2002). Pegylated liposomal doxorubicin in the CHOP regimen for older patients with aggressive (stages III/IV) non-Hodgkin's lymphoma.. PubMed. 22(3). 1845–8.28 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.